drkoop buys drDrew to reach teen marketdrkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings
drkoop buys drDrew to reach teen market
drkoop.com has bought drDrew.com, a healthcare content Web site targeting the 14- to 24-year-old market, for 1.58 million shares in common stock and $150,000 cash. Through the acquisition, which brings drkoop's user base to some two million, drkoop hopes to drive additional licensing revenue and leverage this access to the teen/young adult audience. While drDrew.com will continue to operate as a separate site, the two sites will integrate some content. The acquisition was not a risky move for the beleaguered dot-com and drkoop will continue to evaluate acquiring "undervalued properties," said Ed Cespedes, president of drkoop.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.